The association between TNFR gene polymorphisms and the risk of Hepatitis B Virus-Related Liver Diseases in Chinese population

Abstract Tumor necrosis factor receptor superfamily 2 (TNFR2) plays an important role in controlling the progression of antiviral and antitumorr. Evidence suggests that TNFR2 is involved in the pathogenesis of HBV-induced liver injury. We therefore examined whether TNFR2 polymorphisms are associated...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liping Ma, Siyuan Chen, Xiaohuan Mao, Yu Lu, Xiaolian Zhang, Xianjun Lao, Xue Qin, Shan Li
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/69788b0ae99a490ba9a94cc1a622b9fd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:69788b0ae99a490ba9a94cc1a622b9fd
record_format dspace
spelling oai:doaj.org-article:69788b0ae99a490ba9a94cc1a622b9fd2021-12-02T15:08:43ZThe association between TNFR gene polymorphisms and the risk of Hepatitis B Virus-Related Liver Diseases in Chinese population10.1038/s41598-018-27623-72045-2322https://doaj.org/article/69788b0ae99a490ba9a94cc1a622b9fd2018-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-27623-7https://doaj.org/toc/2045-2322Abstract Tumor necrosis factor receptor superfamily 2 (TNFR2) plays an important role in controlling the progression of antiviral and antitumorr. Evidence suggests that TNFR2 is involved in the pathogenesis of HBV-induced liver injury. We therefore examined whether TNFR2 polymorphisms are associated with the risk of HBV-related liver disease in Chinese population. In this case-control study, 115 chronic hepatitis B (CHB) patients, 86 HBV-related liver cirrhosis patients (LC), 272 HBV-related hepatocellular carcinoma patients (HCC) and 269 healthy controls were recruited. TNFR2 rs1061622 and rs1061624 polymorphisms were examined using a polymerase chain reaction-restriction fragment length polymorphism analysis. Binary logistic regression analyses revealed that the A allele of rs1061624 was positively associated with the risk of CHB (AA vs. GG, P = 0.026; AA vs. GA+GG, P = 0.021), LC (AA vs. GG, P = 0.027; AA+GA vs. GG, P = 0.036), and HCC (GA vs. GG, P = 0.046; GA+AA vs. GG, P = 0.031). Moreover, subgroup analysis indicated that male subjects have increased risk in developing CHB and LC. Nevertheless, no association was found between rs1061622 polymorphism and HBV-related liver diseases in the overall or subgroup analyses. Our retrospective study suggests that the TNFR2 rs1061624 polymorphism is associated with HBV-related CHB, LC, and HCC in Chinese population, particularly in males.Liping MaSiyuan ChenXiaohuan MaoYu LuXiaolian ZhangXianjun LaoXue QinShan LiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-7 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Liping Ma
Siyuan Chen
Xiaohuan Mao
Yu Lu
Xiaolian Zhang
Xianjun Lao
Xue Qin
Shan Li
The association between TNFR gene polymorphisms and the risk of Hepatitis B Virus-Related Liver Diseases in Chinese population
description Abstract Tumor necrosis factor receptor superfamily 2 (TNFR2) plays an important role in controlling the progression of antiviral and antitumorr. Evidence suggests that TNFR2 is involved in the pathogenesis of HBV-induced liver injury. We therefore examined whether TNFR2 polymorphisms are associated with the risk of HBV-related liver disease in Chinese population. In this case-control study, 115 chronic hepatitis B (CHB) patients, 86 HBV-related liver cirrhosis patients (LC), 272 HBV-related hepatocellular carcinoma patients (HCC) and 269 healthy controls were recruited. TNFR2 rs1061622 and rs1061624 polymorphisms were examined using a polymerase chain reaction-restriction fragment length polymorphism analysis. Binary logistic regression analyses revealed that the A allele of rs1061624 was positively associated with the risk of CHB (AA vs. GG, P = 0.026; AA vs. GA+GG, P = 0.021), LC (AA vs. GG, P = 0.027; AA+GA vs. GG, P = 0.036), and HCC (GA vs. GG, P = 0.046; GA+AA vs. GG, P = 0.031). Moreover, subgroup analysis indicated that male subjects have increased risk in developing CHB and LC. Nevertheless, no association was found between rs1061622 polymorphism and HBV-related liver diseases in the overall or subgroup analyses. Our retrospective study suggests that the TNFR2 rs1061624 polymorphism is associated with HBV-related CHB, LC, and HCC in Chinese population, particularly in males.
format article
author Liping Ma
Siyuan Chen
Xiaohuan Mao
Yu Lu
Xiaolian Zhang
Xianjun Lao
Xue Qin
Shan Li
author_facet Liping Ma
Siyuan Chen
Xiaohuan Mao
Yu Lu
Xiaolian Zhang
Xianjun Lao
Xue Qin
Shan Li
author_sort Liping Ma
title The association between TNFR gene polymorphisms and the risk of Hepatitis B Virus-Related Liver Diseases in Chinese population
title_short The association between TNFR gene polymorphisms and the risk of Hepatitis B Virus-Related Liver Diseases in Chinese population
title_full The association between TNFR gene polymorphisms and the risk of Hepatitis B Virus-Related Liver Diseases in Chinese population
title_fullStr The association between TNFR gene polymorphisms and the risk of Hepatitis B Virus-Related Liver Diseases in Chinese population
title_full_unstemmed The association between TNFR gene polymorphisms and the risk of Hepatitis B Virus-Related Liver Diseases in Chinese population
title_sort association between tnfr gene polymorphisms and the risk of hepatitis b virus-related liver diseases in chinese population
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/69788b0ae99a490ba9a94cc1a622b9fd
work_keys_str_mv AT lipingma theassociationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT siyuanchen theassociationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT xiaohuanmao theassociationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT yulu theassociationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT xiaolianzhang theassociationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT xianjunlao theassociationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT xueqin theassociationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT shanli theassociationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT lipingma associationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT siyuanchen associationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT xiaohuanmao associationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT yulu associationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT xiaolianzhang associationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT xianjunlao associationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT xueqin associationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
AT shanli associationbetweentnfrgenepolymorphismsandtheriskofhepatitisbvirusrelatedliverdiseasesinchinesepopulation
_version_ 1718388003290742784